Finance

Lists
Q3 2026 earnings • released • EPS beat +8.76% • Revenue beat +0.94%
See results
6446:TPE
PharmaEssentia Corp
NT$1,365.00
0.00%
(0.00) 1D
Nov 12, 1:30:36 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6446...
Mkt. cap
576.62B
Avg. vol.
2.65M
Volume
0.00
Dividend
0.10%
Quarterly dividend
NT$0.34
Ex-dividend date
Jul 9, 2026
P/E ratio
76.25
52-wk high
NT$1,645.00
52-wk low
NT$407.92
EPS
NT$17.90
No. of employees
131
Mkt. cap
576.62B
Avg. vol.
2.65M
Volume
0.00
Dividend
0.10%
Quarterly dividend
NT$0.34
Ex-dividend date
Jul 9, 2026
P/E ratio
76.25
52-wk high
NT$1,645.00
52-wk low
NT$407.92
EPS
NT$17.90
No. of employees
131
News stories
From web sources and news partners
About PharmaEssentia Corp
CEO-
Employees131
FoundedMay 9, 1990
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepharmaessentia.com
Last report
Nov 11, 2026
Fiscal period
Q3 2026
NT$7.08 / NT$6.51
+8.76%beat
Revenue / Est. (TWD)
7.76B / 7.69B
+0.94%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
4.88B
5.12B
6.86B
7.76B
Cost of goods sold
543.68M
621.28M
395.45M
245.13M
Cost of revenue
543.68M
621.28M
395.45M
245.13M
Research and development expenses
1.01B
857.29M
1.07B
1.22B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.77B
1.56B
2.24B
3.16B
Operating expense
2.78B
2.41B
3.31B
4.39B
Total operating expenses
3.32B
3.03B
3.70B
4.63B
Operating income
1.56B
2.09B
3.15B
3.13B
Other non operating income
4.37M
1.32M
8.58M
-7.94M
EBT including unusual items
2.01B
2.34B
3.20B
3.25B
EBT excluding unusual items
2.01B
2.34B
3.20B
3.25B
Income tax expense
536.45M
185.95M
668.64M
329.44M
Effective tax rate
26.65%
7.96%
20.90%
10.13%
Other operating expenses
-
-
-
-
Net income
1.48B
2.15B
2.53B
2.92B
Net profit margin
30.24%
41.97%
36.90%
37.67%
Earnings per share
3.58
5.21
6.13
7.08
Interest and investment income
142.46M
139.53M
148.04M
142.64M
Interest expense
-5.76M
-4.71M
-5.95M
-8.23M
Net interest expenses
136.70M
134.82M
142.08M
134.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.60B
2.14B
3.21B
3.41B
Gain or loss from assets sale
1.50M
-
-
82.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps